Why an Antibody Humanization Service Is Essential for Translating Antibodies into the Clinic
Introduction Antibody discovery often begins with strong biological activity, but early success does not guarantee clinical viability. One of the most common barriers to translation is immunogenicity. According to analyses referenced by the National Institutes of Health, immune responses against non-human antibody sequences remain a major cause of therapeutic failure during development. This is where…
